By Michael Erman and Kamal Choudhury NEW YORK, Oct 29 (Reuters) – Merck said on Thursday it plans to raise its revenue forecast from new products over the next decade, buoyed by recent clinical trial
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Cash is king, as investors draw new battle lines in AI spending boom
By Aditya Soni and Deborah Mary Sophia Oct 29 (Reuters) - Cash flow is king…
Djokovic out in Basel, Fritz sets up Fils quarter-final
VIDEO SHOWS: ATP 500 SWISS INDOORS BASEL HIGHLIGHTS RESENDING WITH COMPLETE SCRIPT SHOWS: BASEL, SWITZERLAND…
BRIEF-Schoolblazer Requests Trading Halt
Oct 30 (Reuters) - Schoolblazer Ltd: * SCHOOLBLAZER - TRADING HALT REQUESTED PENDING ANNOUNCEMENT ON…
